MIV Therapeutics
Officials from MIV Therapeutics report details of recent activities
Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at MIV Therapeutics.
Report 1: MIV Therapeutics Inc. (MIVT), a developer of next-generation biocompatible polymer-free drug-eluting stents and advanced drug delivery systems, has announced two recent financings totaling $4 million to accelerate the company's ongoing development of next generation stents and to support recent acquisition activity.
MIVT recently ratified and completed a private placement for an aggregate amount of $4 million pursuant to the terms and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-04-29)
More Articles from Lab Business Week
- Biomedical Engineering
New biomedical engineering research has been reported by scientists at Abbott Laboratories - Breast Cancer Genetics
Studies from Chester Beatty Laboratories yield new data on breast cancer genetics - Carrington Laboratories, Inc.
Carrington Announces Information in Compliance with NASDAQ Rules - Charles River Laboratories
Charles River Laboratories Schedules First-Quarter 2007 Earnings Release and Conference Call - Drug Development
Pharmatek Opens New Facility - Epilepsy
Study results from Abbott Laboratories broaden understanding of epilepsy - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
